Literature DB >> 32989107

Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes.

Jennifer L Whitwell1, Nirubol Tosakulwong2, Christopher C Schwarz2, Matthew L Senjem2, Anthony J Spychalla2, Joseph R Duffy2, Jon Graff-Radford2, Mary M Machulda2, Bradley F Boeve2, David S Knopman2, Ronald C Petersen2, Val J Lowe2, Clifford R Jack2, Dennis W Dickson2, Joseph E Parisi2, Keith A Josephs2.   

Abstract

OBJECTIVE: To characterize longitudinal MRI and PET abnormalities in autopsy-confirmed Pick disease (PiD) and determine how patterns of neurodegeneration differ with respect to clinical syndrome.
METHODS: Seventeen patients with PiD were identified who had antemortem MRI (8 with behavioral variant frontotemporal dementia [bvFTD-PiD], 6 with nonfluent/agrammatic primary progressive aphasia [naPPA-PiD], 1 with semantic primary progressive aphasia, 1 with unclassified primary progressive aphasia, and 1 with corticobasal syndrome). Thirteen patients had serial MRI for a total of 56 MRIs, 7 had [18F]fluorodeoxyglucose PET, 4 had Pittsburgh compound B (PiB) PET, and 1 patient had [18F]flortaucipir PET. Cross-sectional and longitudinal comparisons of gray matter volume and metabolism were performed between bvFTD-PiD, naPPA-PiD, and controls. Cortical PiB summaries were calculated to determine β-amyloid positivity.
RESULTS: The bvFTD-PiD and naPPA-PiD groups showed different foci of volume loss and hypometabolism early in the disease, with bvFTD-PiD involving bilateral prefrontal and anterior temporal cortices and naPPA-PiD involving left inferior frontal gyrus, insula, and orbitofrontal cortex. However, patterns merged over time, with progressive spread into prefrontal and anterior temporal lobe in naPPA-PiD, and eventual involvement of posterior temporal lobe, motor cortex, and parietal lobe in both groups. Rates of frontotemporal atrophy were faster in bvFTD-PiD than naPPA-PiD. One patient was β-amyloid-positive on PET with low Alzheimer neuropathologic changes at autopsy. Flortaucipir PET showed elevated uptake in frontotemporal white matter.
CONCLUSION: Patterns of atrophy and hypometabolism differ in PiD according to presenting syndrome, although patterns of neurodegeneration appear to converge over time.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32989107      PMCID: PMC7836669          DOI: 10.1212/WNL.0000000000010948

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Clinical phenotypes in autopsy-confirmed Pick disease.

Authors:  O Piguet; G M Halliday; W G J Reid; B Casey; R Carman; Y Huang; J H Xuereb; J R Hodges; J J Kril
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

2.  Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease.

Authors:  Katherine P Rankin; Mary Catherine Mayo; William W Seeley; Suzee Lee; Gil Rabinovici; Maria Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; John Q Trojanowski; Stephen J DeArmond; Bruce L Miller
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

3.  Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.

Authors:  Katerina A Tetzloff; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Christopher G Schwarz; Matthew L Senjem; Robert I Reid; Jeffrey L Gunter; Anthony J Spychalla; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

4.  The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia.

Authors:  Jennifer L Whitwell; Peter R Martin; Joseph R Duffy; Heather M Clark; Mary M Machulda; Christopher G Schwarz; Stephen D Weigand; Irene Sintini; Matthew L Senjem; Nilufer Ertekin-Taner; Hugo Botha; Rene L Utianski; Jonathan Graff-Radford; David T Jones; Bradley F Boeve; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Neurology       Date:  2019-01-11       Impact factor: 9.910

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.

Authors:  Renaud La Joie; Nagehan Ayakta; William W Seeley; Ewa Borys; Adam L Boxer; Charles DeCarli; Vincent Doré; Lea T Grinberg; Eric Huang; Ji-Hye Hwang; Milos D Ikonomovic; Clifford Jack; William J Jagust; Lee-Way Jin; William E Klunk; Julia Kofler; Orit H Lesman-Segev; Samuel N Lockhart; Val J Lowe; Colin L Masters; Chester A Mathis; Catriona L McLean; Bruce L Miller; Daniel Mungas; James P O'Neil; John M Olichney; Joseph E Parisi; Ronald C Petersen; Howard J Rosen; Christopher C Rowe; Salvatore Spina; Prashanthi Vemuri; Victor L Villemagne; Melissa E Murray; Gil D Rabinovici
Journal:  Alzheimers Dement       Date:  2018-10-19       Impact factor: 21.566

7.  Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Authors:  Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2015-09-25       Impact factor: 10.422

8.  Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.

Authors:  Jonathan D Rohrer; Tammaryn Lashley; Jonathan M Schott; Jane E Warren; Simon Mead; Adrian M Isaacs; Jonathan Beck; John Hardy; Rohan de Silva; Elizabeth Warrington; Claire Troakes; Safa Al-Sarraj; Andrew King; Barbara Borroni; Matthew J Clarkson; Sebastien Ourselin; Janice L Holton; Nick C Fox; Tamas Revesz; Martin N Rossor; Jason D Warren
Journal:  Brain       Date:  2011-09       Impact factor: 13.501

9.  An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Authors:  Val J Lowe; Geoffry Curran; Ping Fang; Amanda M Liesinger; Keith A Josephs; Joseph E Parisi; Kejal Kantarci; Bradley F Boeve; Mukesh K Pandey; Tyler Bruinsma; David S Knopman; David T Jones; Leonard Petrucelli; Casey N Cook; Neill R Graff-Radford; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Melissa E Murray
Journal:  Acta Neuropathol Commun       Date:  2016-06-13       Impact factor: 7.801

10.  β-Amyloid PET and neuropathology in dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Qin Chen; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Clifford R Jack; Jonathan Graff-Radford; David T Jones; David S Knopman; Neill Graff-Radford; Tanis J Ferman; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Bradley F Boeve; Melissa E Murray
Journal:  Neurology       Date:  2019-12-20       Impact factor: 11.800

View more
  4 in total

1.  Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.

Authors:  Lucia A A Giannini; Claire Peterson; Daniel Ohm; Sharon X Xie; Corey T McMillan; Katya Raskovsky; Lauren Massimo; EunRah Suh; Vivianna M Van Deerlin; David A Wolk; John Q Trojanowski; Edward B Lee; Murray Grossman; David J Irwin
Journal:  Acta Neuropathol Commun       Date:  2021-02-23       Impact factor: 7.801

2.  Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.

Authors:  Sarah E Burke; Jeffrey S Phillips; Christopher A Olm; Claire S Peterson; Phillip A Cook; James C Gee; Edward B Lee; John Q Trojanowski; Lauren Massimo; David J Irwin; Murray Grossman
Journal:  Neurobiol Aging       Date:  2022-02-24       Impact factor: 5.133

Review 3.  Tauopathies: new perspectives and challenges.

Authors:  Yi Zhang; Kai-Min Wu; Liu Yang; Qiang Dong; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2022-04-07       Impact factor: 14.195

Review 4.  Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.

Authors:  Bradley T Peet; Salvatore Spina; Nidhi Mundada; Renaud La Joie
Journal:  Neurotherapeutics       Date:  2021-08-13       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.